Archive

  • Coronavirus action plan activated at key German insurer

    02 March 2020

    But trade body says virus still exerting limited influence on country's industry as a whole

  • German insurers slam regulatory 'stranglehold' on economy

    20 January 2020

    GDV chief economist Klaus Wiener calls for a principles-based system

  • German trade bodies criticise BaFin over reporting, proportionality

    11 November 2019

    Regulator replies existing measures to ease burden are appropriate

  • IFRS 17: what insurers dislike from the final consultation

    24 October 2019

    The treatment of reinsurance accounting under IFRS 17 appears to be the most consistent complaint from re/insurers, but deciding when the standard should take effect continues to generate disagreements among stakeholders. Cintia Cheong reports

  • What's next for the MA and VA?

    04 July 2019

    More than €100bn of capital relief is provided by Solvency II's matching and volatility adjustments, but they are far from uncontroversial. As the European Commission begins to consider reforms, Christopher Cundy reports on the problems and possible solutions

  • German life insurers relish €4.5bn-plus saving on ZZR contributions

    14 May 2019

    The revised methodology for calculating Germany's special interest rate reserves is saving billions for the country's life insurers. David Walker reports

  • German insurers want "fundamental reform" of Solvency II reporting

    15 February 2019

    GDV advocates lower reporting requirements for well capitalised companies with lower risk profiles

  • German internal mergers hit 10-year low

    08 February 2019

    GDV says business restructuring at insurers now focuses on IT, products and distribution

  • German insurers fear UK ditching Solvency II rules post-Brexit

    17 January 2019

    Underwriters voice their post-Brexit concerns through their trade body

  • Solvency II: what reforms can we expect?

    27 December 2018

    Christopher Cundy examines what will change with the two scheduled reviews of Solvency II and the other issues set to influence the EU's landmark insurance legislation